Centrum Medyczne ENEL-MED (FRA:E19) Tariff Resilience Score: 0/10 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:E19 Centrum Medyczne ENEL-MED SA FRA:E19
77 GF Score
Price €4.16
GF Value €5.49
! 5 Warning Signs
View Full Analysis

What is Centrum Medyczne ENEL-MED Tariff Resilience Score?

Centrum Medyczne ENEL-MED has the Tariff Resilience Score of 0, which implies that the company might have .

Centrum Medyczne ENEL-MED has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Centrum Medyczne ENEL-MED might have .

Centrum Medyczne ENEL-MED  (FRA:E19) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Centrum Medyczne ENEL-MED Tariff Resilience Score Related Terms

FRA:E19
77GF Score
Centrum Medyczne ENEL-MED SA FRA:E19
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Centrum Medyczne ENEL-MED (FRA:E19) Overvalued in 2026?

Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued. The current stock price of €4.16 is trading 24.2% below its estimated GF Value™ of €5.49.

Key valuation signals for FRA:E19:

  • Tariff Resilience Score: 0
  • GF Value™: €5.49 vs. price of €4.16 (24.2% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:E19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Centrum Medyczne ENEL-MED Business Description

Other Exchanges ENE:Poland
Address ul. Slominskiego 19 lok. 524, Warsaw, POL, 00-195
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
77GF Score

Get the complete analysis for FRA:E19

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.16
Price
€5.49
GF Value